Survival analysis of follow-up results from the 100 clinical cases showed that increased expression of HLA-DQA1 significantly prolonged survival in RCC, while increased expression of IL-34 significantly prolonged survival in LCC. This evidence concerns the gene IL34 and leukoencephalopathy with calcifications and cysts.